SIRT1 and fatty liver disease: BAC-based transgenic mice overexpressing SIRT1 in various tissues exhibited normal fat mass and protected against high-fat diet-induced impaired glucose tolerance and hepatic steatosis due to decreased hepatic glucose production [39], [40].